Bulletin
Diatrizoate Meglumine and Diatrizoate Sodium Injection
05 December 2008
Products Affected - Description
Diatrizoate meglumine 52% / Diatrizoate sodium 8% injection
Renografin-60, 50 mL vial, 10-pack (NDC 00270-0707-49), Bracco Diagnostics - discontinued
Renografin-60, 100 mL bottle, 10-pack (NDC 00270-0707-55), Bracco Diagnostics - discontinued
Diatrizoate meglumine 66% / Diatrizoate sodium 10% injection
Renocal-76, 50 mL vial, 25-pack (NDC 00270-0860-20), Bracco Diagnostics - discontinued
Renocal-76, 100 mL vial, 10-pack (NDC 00270-0860-30), Bracco Diagnostics - discontinued
Renocal-76, 150 mL bottle, 10-pack (NDC 00270-0860-40), Bracco Diagnostics - discontinued
Hypaque-76, 50 mL vial, 25-pack (NDC 00407-0776-04), GE Healthcare - discontinued
Hypaque-76, 200 mL vial, 10-pack (NDC 00407-0778-02), GE Healthcare - discontinued
Reason for the Shortage
- Bracco Diagnostics states that Renografin-60 and Renocal-76 have been discontinued due to reduced demand.
- GE Healthcare has discontinued Hypaque-76 for unknown reasons.
- There are no other manufacturers of diatrizoate meglumine/diatrizoate sodium injection.
Estimated Resupply Dates
Diatrizoate meglumine/diatrizoate sodium injection is discontinued.
Related Shortages
Updated
December 5, 2008, University of Utah, Drug Information Service.
Back to Drug Shortage Product Bulletins